Supplementary Figure S2 from Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C Inhibitors Article Swipe
Hiroyuki Matsubara
,
Hiroyuki Miyoshi
,
Fumihiko Kakizaki
,
Tomonori Morimoto
,
Kenji Kawada
,
Takehito Yamamoto
,
Kazutaka Obama
,
Yoshiharu Sakai
,
Makoto Mark Taketo
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.30733948
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.30733948
Suppl. Fig. S2 with its legend on page 2
Related Topics
Concepts
Metadata
- Type
- article
- Landing Page
- https://doi.org/10.1158/1535-7163.30733948
- OA Status
- gold
- OpenAlex ID
- https://openalex.org/W7106787266
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7106787266Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.30733948Digital Object Identifier
- Title
-
Supplementary Figure S2 from Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C InhibitorsWork title
- Type
-
articleOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-27Full publication date if available
- Authors
-
Hiroyuki Matsubara, Hiroyuki Miyoshi, Fumihiko Kakizaki, Tomonori Morimoto, Kenji Kawada, Takehito Yamamoto, Kazutaka Obama, Yoshiharu Sakai, Makoto Mark TaketoList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.30733948Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1535-7163.30733948Direct OA link when available
- Concepts
-
Medicine, Colorectal cancer, KRAS, Drug, Drug resistance, Oncology, Cancer research, Cancer, Internal medicine, Drug treatment, Cancer treatment, Acquired resistance, Pharmacology, Clinical trialTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W7106787266 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.30733948 |
| ids.doi | https://doi.org/10.1158/1535-7163.30733948 |
| ids.openalex | https://openalex.org/W7106787266 |
| fwci | 0.0 |
| type | article |
| title | Supplementary Figure S2 from Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C Inhibitors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8454325199127197 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C526805850 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6992115378379822 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[1].display_name | Colorectal cancer |
| concepts[2].id | https://openalex.org/C2781187634 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6779224872589111 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q20969980 |
| concepts[2].display_name | KRAS |
| concepts[3].id | https://openalex.org/C2780035454 |
| concepts[3].level | 2 |
| concepts[3].score | 0.529918372631073 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[3].display_name | Drug |
| concepts[4].id | https://openalex.org/C114851261 |
| concepts[4].level | 2 |
| concepts[4].score | 0.43231797218322754 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12147416 |
| concepts[4].display_name | Drug resistance |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3913666307926178 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.37098464369773865 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.33611756563186646 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.32750383019447327 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C2986900798 |
| concepts[9].level | 2 |
| concepts[9].score | 0.3161509335041046 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q5308926 |
| concepts[9].display_name | Drug treatment |
| concepts[10].id | https://openalex.org/C3019816032 |
| concepts[10].level | 3 |
| concepts[10].score | 0.30272477865219116 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2575340 |
| concepts[10].display_name | Cancer treatment |
| concepts[11].id | https://openalex.org/C2994294914 |
| concepts[11].level | 3 |
| concepts[11].score | 0.29537680745124817 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1645075 |
| concepts[11].display_name | Acquired resistance |
| concepts[12].id | https://openalex.org/C98274493 |
| concepts[12].level | 1 |
| concepts[12].score | 0.2946704924106598 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[12].display_name | Pharmacology |
| concepts[13].id | https://openalex.org/C535046627 |
| concepts[13].level | 2 |
| concepts[13].score | 0.2647415101528168 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[13].display_name | Clinical trial |
| keywords[0].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[0].score | 0.6992115378379822 |
| keywords[0].display_name | Colorectal cancer |
| keywords[1].id | https://openalex.org/keywords/kras |
| keywords[1].score | 0.6779224872589111 |
| keywords[1].display_name | KRAS |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.529918372631073 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/drug-resistance |
| keywords[3].score | 0.43231797218322754 |
| keywords[3].display_name | Drug resistance |
| keywords[4].id | https://openalex.org/keywords/cancer |
| keywords[4].score | 0.33611756563186646 |
| keywords[4].display_name | Cancer |
| keywords[5].id | https://openalex.org/keywords/drug-treatment |
| keywords[5].score | 0.3161509335041046 |
| keywords[5].display_name | Drug treatment |
| language | |
| locations[0].id | doi:10.1158/1535-7163.30733948 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.30733948 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A2025697146 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9279-5458 |
| authorships[0].author.display_name | Hiroyuki Matsubara |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hiroyuki Matsubara |
| authorships[0].is_corresponding | True |
| authorships[1].author.id | https://openalex.org/A2150578281 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7400-0714 |
| authorships[1].author.display_name | Hiroyuki Miyoshi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Hiroyuki Miyoshi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A1978691034 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2017-6700 |
| authorships[2].author.display_name | Fumihiko Kakizaki |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Fumihiko Kakizaki |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A2427074815 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0535-0889 |
| authorships[3].author.display_name | Tomonori Morimoto |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Tomonori Morimoto |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A1938911419 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-4336-6937 |
| authorships[4].author.display_name | Kenji Kawada |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kenji Kawada |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A2106142404 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2236-7124 |
| authorships[5].author.display_name | Takehito Yamamoto |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Takehito Yamamoto |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A2058599804 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2924-6701 |
| authorships[6].author.display_name | Kazutaka Obama |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kazutaka Obama |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A2163678501 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9864-4186 |
| authorships[7].author.display_name | Yoshiharu Sakai |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Yoshiharu Sakai |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A2250506730 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Makoto Mark Taketo |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Makoto Mark Taketo |
| authorships[8].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1535-7163.30733948 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-28T00:00:00 |
| display_name | Supplementary Figure S2 from Efficacious Combination Drug Treatment for Colorectal Cancer That Overcomes Resistance to KRAS G12C Inhibitors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T02:12:24.556248 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1535-7163.30733948 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.30733948 |
| primary_location.id | doi:10.1158/1535-7163.30733948 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.30733948 |
| publication_date | 2025-11-27 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.S2 | 2 |
| abstract_inverted_index.on | 6 |
| abstract_inverted_index.its | 4 |
| abstract_inverted_index.Fig. | 1 |
| abstract_inverted_index.page | 7 |
| abstract_inverted_index.with | 3 |
| abstract_inverted_index.legend | 5 |
| abstract_inverted_index.2</p> | 8 |
| abstract_inverted_index.<p>Suppl. | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile |